Cart summary

You have no items in your shopping cart.

PPARγ agonist 4

PPARγ agonist 4

Catalog Number: orb1688305

DispatchUsually dispatched within 6-8 weeks
Contact us for a quotation
Catalog Numberorb1688305
CategorySmall Molecules
DescriptionPPARγ agonist 4
Purity98.00%
MW387.45
Biological ActivityPPARγ agonist 4 (Compound 18b), a potent and selective PPARγ agonist, demonstrates antitumor efficacy only when used in conjunction with Imatinib. Notably, PPARγ agonist 4 does not exhibit cytotoxic effects on either non-resistant or resistant cells [1].
CAS Number2380227-06-3
FormulaC24H22FN3O
SMILESC(N1C=2C(N=C1CCC)=C(F)C=CC2)C3=CC=C(C=C3)C4=C(C(N)=O)C=CC=C4
Storage-20°C
NoteFor research use only
  • Rosiglitazone [orb1226757]

    > 98% (HPLC)

    122320-73-4

    357.4

    C18H19N3O3S

    25 mg, 50 mg, 100 mg, 200 mg, 1 g, 500 mg
  • XY-4 [orb1979983]

    98.00%

    474329-47-0

    430.46

    C19H37F2O6P

    500 μg
  • (±)4-HDHA [orb1985040]

    99.05%

    90906-40-4

    344.49

    C22H32O3

    50 μg, 5 mg, 25 mg, 10 mg, 1 mg, 100 μg, 25 μg
  • 17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid [orb1984945]

    98.00%

    1233715-28-0

    342.479

    C22H30O3

    250 μg, 50 μg, 25 μg, 100 μg
  • 4-oxo Docosahexaenoic Acid [orb1985014]

    98.00%

    845673-74-7

    342.479

    C22H30O3

    50 μg, 100 μg, 25 μg, 250 μg